Insights

Insights and perspectives

Thinking from Dr. Donald Munroe on AI-enabled diagnostics, IVD strategy, regulation, reimbursement, and R&D leadership, plus white papers, talks, and where to find us.

Perspectives

What we write and advise on

Evergreen themes at the intersection of diagnostics, AI, regulation, and R&D leadership.

AI

AI-Enabled Diagnostics

Integrating AI into digital pathology, imaging, and multiomics workflows, from concept to clinical impact.

Regulatory

IVD Regulatory Strategy

FDA and IVDR pathways, with design-for-reliability and manufacturability built in upstream of development.

Policy

The Future of LDTs

Navigating the shifting US regulatory landscape for laboratory-developed tests.

Operations

R&D Operating Models

The operating models shaping diagnostics innovation, and how to choose among them.

Market Access

Evidence & Reimbursement

Clinical utility, health economics, CPT coding, CMS decisions, and payer advocacy.

Leadership

Lean-Agile R&D

Portfolio governance and agile operating systems that sustain predictable execution.

White Papers & Resources

White Paper · 2025

Harnessing Artificial Intelligence to Elevate Lean Six Sigma Principles

Where AI raises the ceiling on Lean Six Sigma in R&D and operations.

Request the PDF

Talk · Feb 2025

7 Hard Startup Lessons from a Panel at Anchor Ventures

Field-tested lessons for founders and operators in health tech.

Request the PDF

Press Release · Mar 2025

Dr. Donald Munroe Appointed to Edgewater Talent Advisory Board

Advisory Board appointment at Edgewater Talent.

Read more

White Paper · Jan 2025

The Future of LDTs in the USA

A perspective on laboratory-developed tests and the shifting regulatory landscape.

Request the PDF

In the Field

Speaking & events

  • 2025

    BIO Boston 2025

    Five critical R&D operating models shaping diagnostics innovation. Read the recap.

  • Feb 2025

    Anchor Ventures Founder Panel

    Seven hard startup lessons for health-tech founders and operators.

  • Ongoing

    CMS, FDA & payer presentations

    Advancing coverage, coding, and clinical-guideline decisions for novel diagnostics to improve cost, quality, and access.

From LinkedIn

Latest thinking

LinkedIn Article

During BIO Boston 2025: five critical R&D operating models

Five operating models shaping innovation, explored during BIO Boston 2025.

Read on LinkedIn

LinkedIn Article

Andrew Van Ella joins the Edgewater Talent leadership team

Welcoming Andrew Van Ella to the Edgewater Talent leadership team.

Read on LinkedIn

Subscribe to the newsletter

Have a strategic challenge worth solving?

Schedule Strategic Consultation